These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 1663819
1. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys. Seymour AA, Abboa-Offei B, Asaad MM, Rogers WL. Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819 [Abstract] [Full Text] [Related]
2. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase. Seymour AA, Norman JA, Asaad MM, Fennell SA, Little DK, Kratunis VJ, Rogers WL. J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235 [Abstract] [Full Text] [Related]
3. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure. Seymour AA, Asaad MM, Lanoce VM, Fennell SA, Cheung HS, Rogers WL. Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758 [Abstract] [Full Text] [Related]
4. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors. Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Rogers WL, Dorso CR. J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340 [Abstract] [Full Text] [Related]
5. Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072. Seymour AA, Fennell SA, Swerdel JN. Hypertension; 1989 Jul; 14(1):87-97. PubMed ID: 2544529 [Abstract] [Full Text] [Related]
6. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats. Seymour AA, Asaad MM, Abboa-Offei BE, Rovnyak PL, Fennell S, Rogers WL. J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630 [Abstract] [Full Text] [Related]
7. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers WL. J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922 [Abstract] [Full Text] [Related]
8. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. Willenbrock R, Scheuermann M, Höhnel K, Luft FC, Dietz R. Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733 [Abstract] [Full Text] [Related]
9. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat. Wilkins MR, Settle SL, Kirk JE, Taylor SA, Moore KP, Unwin RJ. Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165 [Abstract] [Full Text] [Related]
10. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors. Seymour AA, Norman JA, Asaad MM, Fennell SA, Abboa-Offei B, Little DK, Kratunis VJ, Delaney NG, Hunt JT, Di Donato G. J Pharmacol Exp Ther; 1991 Mar; 256(3):1002-9. PubMed ID: 1826031 [Abstract] [Full Text] [Related]
11. Atrial natriuretic peptide in chronically hypertensive dogs. Seymour AA, Asaad MM, Sheldon JH, Smith PL, Rogers WL. Hypertension; 1995 Oct; 26(4):634-41. PubMed ID: 7558224 [Abstract] [Full Text] [Related]
12. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats. Pham I, el Amrani AI, Fournié-Zaluski MC, Corvol P, Roques B, Michel JB. J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584 [Abstract] [Full Text] [Related]
13. Sodium loads enhance the natriuretic responses to atrial natriuretic peptide and neutral endopeptidase inhibitors in conscious cynomolgus monkeys. Seymour AA, Asaad MM, Abboa-Offei B, Smith PL, Rogers WL. Clin Exp Pharmacol Physiol; 1994 Nov; 21(11):845-56. PubMed ID: 7882575 [Abstract] [Full Text] [Related]
14. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure. Rademaker MT, Charles CJ, Espiner EA, Nicholls MG, Richards AM, Kosoglou T. Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410 [Abstract] [Full Text] [Related]
15. Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors. Seymour AA, Mathers PD, Abboa-Offei BE, Asaad MM, Weber H. J Cardiovasc Pharmacol; 1996 Sep; 28(3):397-401. PubMed ID: 8877586 [Abstract] [Full Text] [Related]
16. Effect of endopeptidase-24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat. Kirk JE, Wilkins MR. Br J Pharmacol; 1993 Sep; 110(1):350-4. PubMed ID: 8220896 [Abstract] [Full Text] [Related]
17. Comparison of renal actions of urodilatin and atrial natriuretic peptide. Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Am J Physiol; 1992 Mar; 262(3 Pt 2):R395-9. PubMed ID: 1313650 [Abstract] [Full Text] [Related]
18. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers. Rousso P, Buclin T, Nussberger J, Décosterd LA, La Roche SD, Brunner-Ferber F, Brunner HR, Biollaz J. J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082 [Abstract] [Full Text] [Related]
19. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors. Seymour AA, Abboa-Offei BE, Smith PL, Mathers PD, Asaad MM, Rogers WL. Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):63-9. PubMed ID: 7768036 [Abstract] [Full Text] [Related]